For research use only. Not for therapeutic Use.
(S)-Silodosin(CAT: C000328) plays a pivotal role in the field of pharmaceuticals, particularly in the context of treating benign prostatic hyperplasia (BPH). It serves as a stereoisomer of silodosin, a potent α1A-adrenoceptor antagonist. By specifically blocking α1A-adrenergic receptors, silodosin aids in relieving symptoms associated with BPH, such as urinary hesitancy and frequency. The stereoisomeric variation, (S)-silodosin, highlights the significance of stereochemistry in drug development and reinforces the tailored approach to pharmacologic action.
| Catalog Number | C000328 |
| CAS Number | 2182279-45-2 |
| Synonyms | (S)-1-(3-Hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide |
| Molecular Formula | C₂₅H₃₂F₃N₃O₄ |
| Purity | ≥95% |
| Solubility | Hexanes (Slightly, Heated, Sonicated), Methanol (Slightly, Heated, Sonicated) |
| Appearance | Off-White to Pale Brown Solid |
| Storage | 4°C |
| Reference | Shibata, K., et al.: Mol. Pharmacol., 48, 250 (1995), Murata, S., et al.: J. Urol., 164, 578 (2000), |
